SA CORONA VIRUS WEBSITE
COVID-19
|
SUBSCRIBE
|
FAQs
HOME
ABOUT US
WHO WE ARE
THE SAHPRA BOARD
EXECUTIVE MANAGEMENT
REGULATORY PARTNERSHIP
SPECIAL PROJECTS
BACKLOG
Expressions of Interest
VACANCIES
NEWS
LATEST NEWS & UPDATES
PRESS RELEASES
NDOH UPDATES
PRESENTATIONS
PUBLIC INFORMATION PORTAL
THC & CBD INFORMATION
SAFETY ALERTS
SAHPRA PODCASTS
SAHPRA TV
UPCOMING EVENTS
WORKSHOPS AND CONFERENCES
HEALTH PRODUCTS
ORTHODOX MEDICINES
COMMUNICATION TO INDUSTRY
GUIDELNES
FORMS
TEMPLATES
BIOLOGICAL PRODUCTS
APPLICATION FORMS
COMMUNICATION TO INDUSTRY
GUIDELINES
COMPLEMENTARY MEDICINES
APPLICATION FORMS
COMMUNICATION TO INDUSTRY
GUIDELINES
TEMPLATES
MEDICAL DEVICES
APPLICATION FORMS
COMMUNICATION TO INDUSTRY
GUIDELINES
MEDICAL DEVICES LICENCES ISSUED
POSITION STATEMENTS
RELATED DOCUMENTS
TEST KITS
RADIATION CONTROL
ACTS AND REGULATIONS
APPLICATION AND REPORT FORMS
GUIDELNES AND CODES OF PRACTICE
REGISTERED HEALTH PRODUCTS
UNREGISTERED PRODUCTS
GUIDELINES
VETERINARY MEDICINES
GUIDELNES
LIST OF REGISTERED VETERINARY PRODUCT
E-SERVICES
ACCESS TO UNREGISTERED HEALTH PODUCTS
ADVERSE DRUG REACTION REPORTING
AEFI REPORTING DASHBOARD
COMPLEMENTARY MEDICINES LICENSING
COVI-VIG REPORTING SYSTEM
HEALTH PRODUCT APPLICATION STATUS CHECKER
OTC Medicines Directory
PRODUCT VARIATIONS PORTAL
MED SAFETY APP
VETERINARY PORTAL
PUBLICATIONS
ACTS AND REGULATIONS
ANNUAL REPORTS
GOVERNMENT GAZETTES AND REGULATIONS
GUIDELINES
COMMUNICATION TO INDUSTRY
DOCUMENTS FOR COMMENT
FEES
NAMES AND SCHEDULING
NEWSLETTERS
POLICIES
PRESENTATIONS
SAHPRA PLANNING DOCUMENTS
TENDERS
CONTACT US
HEAD OFFICE
KEY CONTACTS
MEDIA ENQUIRIES
FEEDBACK AND COMPLAINTS
LODGE A COMPLAINT ON MEDICINES AND MEDICAL DEVICES
WHISTLEBLOWER
HOME
ABOUT US
WHO WE ARE
THE SAHPRA BOARD
EXECUTIVE MANAGEMENT
REGULATORY PARTNERSHIP
SPECIAL PROJECTS
BACKLOG
Expressions of Interest
VACANCIES
NEWS
LATEST NEWS & UPDATES
PRESS RELEASES
NDOH UPDATES
PRESENTATIONS
PUBLIC INFORMATION PORTAL
THC & CBD INFORMATION
SAFETY ALERTS
SAHPRA PODCASTS
SAHPRA TV
UPCOMING EVENTS
WORKSHOPS AND CONFERENCES
HEALTH PRODUCTS
ORTHODOX MEDICINES
COMMUNICATION TO INDUSTRY
GUIDELNES
FORMS
TEMPLATES
BIOLOGICAL PRODUCTS
APPLICATION FORMS
COMMUNICATION TO INDUSTRY
GUIDELINES
COMPLEMENTARY MEDICINES
APPLICATION FORMS
COMMUNICATION TO INDUSTRY
GUIDELINES
TEMPLATES
MEDICAL DEVICES
APPLICATION FORMS
COMMUNICATION TO INDUSTRY
GUIDELINES
MEDICAL DEVICES LICENCES ISSUED
POSITION STATEMENTS
RELATED DOCUMENTS
TEST KITS
RADIATION CONTROL
ACTS AND REGULATIONS
APPLICATION AND REPORT FORMS
GUIDELNES AND CODES OF PRACTICE
REGISTERED HEALTH PRODUCTS
UNREGISTERED PRODUCTS
GUIDELINES
VETERINARY MEDICINES
GUIDELNES
LIST OF REGISTERED VETERINARY PRODUCT
E-SERVICES
ACCESS TO UNREGISTERED HEALTH PODUCTS
ADVERSE DRUG REACTION REPORTING
AEFI REPORTING DASHBOARD
COMPLEMENTARY MEDICINES LICENSING
COVI-VIG REPORTING SYSTEM
HEALTH PRODUCT APPLICATION STATUS CHECKER
OTC Medicines Directory
PRODUCT VARIATIONS PORTAL
MED SAFETY APP
VETERINARY PORTAL
PUBLICATIONS
ACTS AND REGULATIONS
ANNUAL REPORTS
GOVERNMENT GAZETTES AND REGULATIONS
GUIDELINES
COMMUNICATION TO INDUSTRY
DOCUMENTS FOR COMMENT
FEES
NAMES AND SCHEDULING
NEWSLETTERS
POLICIES
PRESENTATIONS
SAHPRA PLANNING DOCUMENTS
TENDERS
CONTACT US
HEAD OFFICE
KEY CONTACTS
MEDIA ENQUIRIES
FEEDBACK AND COMPLAINTS
LODGE A COMPLAINT ON MEDICINES AND MEDICAL DEVICES
WHISTLEBLOWER
Covid-19 Tag
Home
>
Posts tagged "Covid-19"
News & Updates
Press Releases
SAHPRA registers the COVID-19 vaccine, Coronavac
June 24, 2022
News & Updates
The Dynamics of Assuming a New CEO or Leadership Role under Global Lockdown Restrictions
June 17, 2022
News & Updates
Press Releases
SAHPRA registers a vaccine and provides emergency use authorisation of health products in the fight against COVID-19
June 7, 2022
News & Updates
Press Releases
SAHPRA Comments on ACDP court matter on vaccines for minors
May 3, 2022
News & Updates
SAHPRA assigns a non-compliant rating to the Emergent BioSolutions COVID-19 facility
March 31, 2022
News & Updates
Press Releases
SAHPRA clarifies the risks and benefits of the Pfizer Comirnaty vaccine
March 11, 2022
News & Updates
SAHPRA has authorised access to molnupiravir
February 17, 2022
News & Updates
SAHPRA registers two COVID-19 vaccines
February 7, 2022
News & Updates
Press Releases
SAHPRA approval of second/booster dose of the COVID-19 vaccine Janssen
December 8, 2021
News & Updates
Press Releases
SAHPRA approval of booster dosing with the Pfizer (Comirnaty®) COVID-19 vaccine
December 8, 2021
1
2
3
